your badges 52W Range $14–$27 8% of range Analyst Rating BUY 10 analysts Price Target $42 +186% upside P/E · ROE · Net Profit Margin ·

KARD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $14.79
Market Cap (MRQ) $1.38B
52W Range $14–$27

KARD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend KARD 5Y avg Peer Median Verdict
P/B (MRQ) 2.2 · · ·
Price / Tangible Book (MRQ) 2.3 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -297.6%
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 $-2.89 $-0.73 -297.6%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
No annual filings for KARD

We don't have SEC filings for this ticker yet.

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
No data for this statement

Not enough fundamentals data to build this statement yet.

Activists & 5%+ owners 3 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Joseph Edelman, Perceptive Advisors LLC, Perceptive Capital Solutions Holdings LP, Perceptive Life Sciences Master Fund, Ltd. Oct. 1, 2026 8.80% Amendment Board campaign SEC
ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, Robert Nelsen, Keith Crandell, Kristina Burow, Steven Gillis, Paul Berns June 29, 2026 16.20% Initial filing Passive investment SEC
Perceptive Advisors LLC, Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., Perceptive Capital Solutions Holdings LP June 25, 2026 8.90% Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 11 insiders · 5 officers · 7 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Anastasios Gianakakos President & CEO June 17, 2026 C 498,692 0 0 $0
Brianne Jahn Chief Financial Officer June 17, 2026 A 79,640 0 0 $0
Jay Edelberg Chief Medical Officer June 17, 2026 C 183,327 0 0 $0
Andy Pasternak Chief Strategy Officer June 17, 2026 A 79,640 0 0 $0
John B Moriarty Chief Legal Officer June 17, 2026 A 47,784 0 0 $0
Kristin Marie K Reinke Director Sept. 29, 2026 A · 0 0 $0
Paul L Berns Director June 22, 2026 P 15,042,035 1 0 $20,000,000
Douglas E. Giordano Director June 17, 2026 A 20,706 0 0 $0
David P Meeker Director June 17, 2026 A 20,706 0 0 $0
Timothy P Walbert Director June 17, 2026 A 20,706 0 0 $0
Kimberly J Popovits Director June 17, 2026 A 20,706 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 6 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 33,254 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 94,522 SH Aug. 19, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.00% 15,856 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.00% 588 SH Aug. 19, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.00% 1,538 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 267 SH Aug. 19, 2026 Daily

KARD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 10 analysts BUY
Median target $43.00 +190.7%
4 40.0% Strong Buy
5 50.0% Buy
1 10.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

4 analysts · 2026-10-01

Mean target $42.25 +185.7%

← Below all targets Current price $14.79
Low$37.00 Mean$42.25 High$46.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
KARD · · · · · ·
NKTR $862M -4.3 -43.9% -297.1% -500.1% ·
PAHC · 12.9 17.1% 6.6% 29.7% 33.8%
INVA · 6.1 14.7% · · ·
MAZE $2.04B -13.6 · · -598.9% ·
XERS $1.30B · 43.7% 0.19% -19.7% ·
OMER $1.23B -343.6 · · 1.9% ·
AVLN · · · · · ·
LBRX $563M -7.1 · · -25.5% ·
HROW $1.82B -350.0 36.4% -1.9% -8.4% 75.0%
YARW · · · · · ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 11, 2026